From: Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Outcome | Analysis | Variable | AECOPD (n = 717) | any COPD (n = 2573) | Respiratory failure (n = 265) | |||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |||
30-day mortalityb | Univariate | Continuous | 2.2 (1.5–3.2) | < 0.0001 | 2.5 (2.1–2.9) | < 0.0001 | 1.5 (1.0–2.1) | 0.04 |
1.quartile | 1 | 1 | 1 | |||||
2.quartile | 1.6 (0.5–4.9) | 0.42 | 2.0 (1.1–3.5) | 0.02 | 1.2 (0.6–2.7) | 0.62 | ||
3.quartile | 3.3 (1.2–9.0) | 0.02 | 3.3 (1.9–5.6) | < 0.0001 | 1.1 (0.5–2.4) | 0.82 | ||
4.quartile | 3.7 (1.4–10.1) | 0.01 | 7.6 (4.6–12-6) | < 0.0001 | 1.8 (0.9–3.7) | 0.12 | ||
Multivariatea | Continuous | 1.8 (1.2–2.8) | 0.005 | 2.0 (1.7–2.4) | < 0.0001 | 1.3 (0.8–2.0) | 0.23 | |
1.quartile | 1 | 1 | 1 | |||||
2.quartile | 1.2 (0.4–3.8) | 0.73 | 1.5 (0.8–2.6) | 0.20 | 1.2 (0.5–2.7) | 0.66 | ||
3.quartile | 2.3 (0.8–6.6) | 0.11 | 1.8 (1.1–3.2) | 0.03 | 0.8 (0.4–1.9) | 0.65 | ||
4.quartile | 2.0 (0.7–5.7) | 0.20 | 3.4 (2.0–5.9) | < 0.0001 | 1.3 (0.6–2.8) | 0.50 | ||
90-day mortalityc | Univariate | Continuous | 2.5 (2.0–3.3) | < 0.0001 | 2.3 (2.1–2.6) | < 0.0001 | 1.5 (1.1–2.2) | 0.01 |
1.quartile | 1 | 1 | 1 | |||||
2.quartile | 2.1 (0.9–5.3) | 0.1 | 1.9 (1.2–2.9) | 0.007 | 1.1 (0.6–2.4) | 0.72 | ||
3.quartile | 4.9 (2.2–11-1) | 0.0001 | 3.6 (2.4–5.4) | < 0.0001 | 1.0 (0.5–2.1) | 0.98 | ||
4.quartile | 7.1 (3.2–15.8) | < 0.0001 | 7.3 (4.9–10.8) | < 0.0001 | 1.6 (0.8–3.1) | 0.20 | ||
Multivariatea | Continuous | 2.2 (1.6–2.9) | < 0.0001 | 2.3 (2.1–2.6) | < 0.0001 | 1.4 (1.0–2.1) | 0.06 | |
1.quartile | 1 | 1 | 1 | |||||
2.quartile | 1.8 (0.7–4.5) | 0.19 | 1.5 (0.8–2.6) | 0.20 | 1.1 (0.6–2.4) | 0.72 | ||
3.quartile | 3.9 (1.7–8.9) | 0.001 | 1.8 (1.1–3.2) | 0.03 | 1.0 (0.5–2.1) | 0.98 | ||
4.quartile | 4.3 (1.9–9.9) | 0.0005 | 3.4 (2.0–5.9) | < 0.0001 | 1.6 (0.8–3.1) | 0.20 |